Kaplan-Meier analysis showed that overall survival was significantly shorter in pancreatic cancer patients with high NAMPT expression levels, whereas overall survival was not affected by NMNAT2 expression. This evidence concerns the gene NMNAT2 and familial pancreatic carcinoma.